Since PD-L1 expression on tumor cells has been used widely as a predictive marker for efficacy of ICI therapy 33, to further analyze the relationship, the expression of RECK and PD-L1 in HCC tissues were assessed by immunohistochemistry staining of human HCC tissue microarray (Figure 7A). This evidence concerns the gene RECK and hepatocellular carcinoma.